Glycomimetics Stock Market Value
| GLYC Stock | USD 0.32 0.03 10.34% |
| Symbol | GlycoMimetics |
GlycoMimetics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlycoMimetics. If investors know GlycoMimetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlycoMimetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Quarterly Revenue Growth (1.00) | Return On Assets (0.59) | Return On Equity (1.04) |
The market value of GlycoMimetics is measured differently than its book value, which is the value of GlycoMimetics that is recorded on the company's balance sheet. Investors also form their own opinion of GlycoMimetics' value that differs from its market value or its book value, called intrinsic value, which is GlycoMimetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlycoMimetics' market value can be influenced by many factors that don't directly affect GlycoMimetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlycoMimetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if GlycoMimetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlycoMimetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GlycoMimetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GlycoMimetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GlycoMimetics.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in GlycoMimetics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding GlycoMimetics or generate 0.0% return on investment in GlycoMimetics over 30 days. GlycoMimetics is related to or competes with Mineralys Therapeutics,, Foghorn Therapeutics, Inventiva, Dyne Therapeutics, Trevi Therapeutics, Cue Biopharma, and AN2 Therapeutics. GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomime... More
GlycoMimetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GlycoMimetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GlycoMimetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.27 | |||
| Information Ratio | 0.0795 | |||
| Maximum Drawdown | 201.39 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 7.14 |
GlycoMimetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GlycoMimetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GlycoMimetics' standard deviation. In reality, there are many statistical measures that can use GlycoMimetics historical prices to predict the future GlycoMimetics' volatility.| Risk Adjusted Performance | 0.0746 | |||
| Jensen Alpha | 2.29 | |||
| Total Risk Alpha | (1.69) | |||
| Sortino Ratio | 0.2605 | |||
| Treynor Ratio | (0.85) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlycoMimetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GlycoMimetics Backtested Returns
GlycoMimetics is out of control given 3 months investment horizon. GlycoMimetics holds Efficiency (Sharpe) Ratio of 0.1, which attests that the entity had a 0.1% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.45% are justified by taking the suggested risk. Use GlycoMimetics Risk Adjusted Performance of 0.0746, market risk adjusted performance of (0.84), and Downside Deviation of 7.27 to evaluate company specific risk that cannot be diversified away. GlycoMimetics holds a performance score of 7 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -2.36, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning GlycoMimetics are expected to decrease by larger amounts. On the other hand, during market turmoil, GlycoMimetics is expected to outperform it. Use GlycoMimetics potential upside and the relationship between the skewness and period momentum indicator , to analyze future returns on GlycoMimetics.
Auto-correlation | -0.12 |
Insignificant reverse predictability
GlycoMimetics has insignificant reverse predictability. Overlapping area represents the amount of predictability between GlycoMimetics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GlycoMimetics price movement. The serial correlation of -0.12 indicates that less than 12.0% of current GlycoMimetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
GlycoMimetics lagged returns against current returns
Autocorrelation, which is GlycoMimetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GlycoMimetics' stock expected returns. We can calculate the autocorrelation of GlycoMimetics returns to help us make a trade decision. For example, suppose you find that GlycoMimetics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GlycoMimetics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GlycoMimetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GlycoMimetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GlycoMimetics stock over time.
Current vs Lagged Prices |
| Timeline |
GlycoMimetics Lagged Returns
When evaluating GlycoMimetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GlycoMimetics stock have on its future price. GlycoMimetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GlycoMimetics autocorrelation shows the relationship between GlycoMimetics stock current value and its past values and can show if there is a momentum factor associated with investing in GlycoMimetics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether GlycoMimetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GlycoMimetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Glycomimetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Glycomimetics Stock:Check out GlycoMimetics Correlation, GlycoMimetics Volatility and GlycoMimetics Alpha and Beta module to complement your research on GlycoMimetics. For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
GlycoMimetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.